% alzhub.org library filter
% Source: https://alzhub.org/research?author=Basun+H&institution=I28166907
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{vedin2012-22545106,
  author  = {Vedin, I. and Cederholm, T. and Freund-Levi, Y. and Basun, H. and Garlind, A. and Irving, G. F. and Eriksdotter-Jönhagen, M. and Wahlund, L. O. and others},
  title   = {{Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study}},
  journal = {PloS one},
  year    = {2012},
  doi     = {10.1371/journal.pone.0035425},
  pmid    = {22545106},
  url     = {https://doi.org/10.1371/journal.pone.0035425}
}

@article{freundlevi2008-17582225,
  author  = {Freund-Levi, Y. and Basun, H. and Cederholm, T. and Faxén-Irving, G. and Garlind, A. and Grut, M. and Vedin, I. and Palmblad, J. and others},
  title   = {{Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms}},
  journal = {International journal of geriatric psychiatry},
  year    = {2008},
  doi     = {10.1002/gps.1857},
  pmid    = {17582225},
  url     = {https://doi.org/10.1002/gps.1857}
}

@article{karimi2017-28855224,
  author  = {Karimi, M. and Vedin, I. and Freund Levi, Y. and Basun, H. and Faxén Irving, G. and Eriksdotter, M. and Wahlund, L. O. and Schultzberg, M. and others},
  title   = {{DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study}},
  journal = {The American journal of clinical nutrition},
  year    = {2017},
  doi     = {10.3945/ajcn.117.155648},
  pmid    = {28855224},
  url     = {https://doi.org/10.3945/ajcn.117.155648}
}

@article{wang2001-11342684,
  author  = {Wang, H. X. and Wahlin, A. and Basun, H. and Fastbom, J. and Winblad, B. and Fratiglioni, L.},
  title   = {{Vitamin B(12) and folate in relation to the development of Alzheimer's disease}},
  journal = {Neurology},
  year    = {2001},
  doi     = {10.1212/wnl.56.9.1188},
  pmid    = {11342684},
  url     = {https://doi.org/10.1212/wnl.56.9.1188}
}

@article{jensen1999-10211475,
  author  = {Jensen, M. and Schröder, J. and Blomberg, M. and Engvall, B. and Pantel, J. and Ida, N. and Basun, H. and Wahlund, L. O. and others},
  title   = {{Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression}},
  journal = {Annals of neurology},
  year    = {1999},
  doi     = {10.1002/1531-8249(199904)45:4<504::aid-ana12>3.0.co;2-9},
  pmid    = {10211475},
  url     = {https://doi.org/10.1002/1531-8249(199904)45:4<504::aid-ana12>3.0.co;2-9}
}

@article{basun2008-18413473,
  author  = {Basun, H. and Bogdanovic, N. and Ingelsson, M. and Almkvist, O. and Näslund, J. and Axelman, K. and Bird, T. D. and Nochlin, D. and others},
  title   = {{Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2008},
  doi     = {10.1001/archneur.65.4.499},
  pmid    = {18413473},
  url     = {https://doi.org/10.1001/archneur.65.4.499}
}

@article{basun2002-12218259,
  author  = {Basun, H. and Nilsberth, C. and Eckman, C. and Lannfelt, L. and Younkin, S.},
  title   = {{Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2002},
  doi     = {10.1159/000063605},
  pmid    = {12218259},
  url     = {https://doi.org/10.1159/000063605}
}